May 20, 2026 07:00AM

Mar 25, 2026 07:00AM

Mar 23, 2026 07:00AM

Oct 15, 2025 07:00AM

Oct 15, 2025 07:00AM

Sep 25, 2025 07:00AM

Sep 4, 2025 07:00AM Algernon Pharmaceuticals changes name to Algernon Health

Sep 4, 2025 07:00AM

May 13, 2025 07:00AM

Jul 16, 2024 08:00AM

Mar 27, 2024 12:04PM

Nov 22, 2023 07:00AM

Jun 27, 2023 07:00AM

Jan 9, 2023 07:00AM Algernon Pharmaceuticals Announces Plans for a 180 Patient Phase 2b Chronic Cough Study of Ifenprodil

Dec 5, 2022 07:00AM

Sep 19, 2022 07:00AM

Sep 1, 2022 07:00AM

Jul 18, 2022 08:00AM

Feb 23, 2022 07:00AM

Jan 14, 2022 08:15AM

Dec 2, 2021 07:00AM Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial

Nov 24, 2021 07:00AM

Oct 15, 2021 12:00PM

Oct 13, 2021 07:00AM

Oct 8, 2021 07:00AM

Sep 22, 2021 07:30AM

Sep 20, 2021 07:00AM

Aug 11, 2021 07:00AM Algernon Pharmaceuticals Announces Small Cell Lung Cancer Ifenprodil Research Program and Appoints Dr. William North as Lead Consultant

Aug 9, 2021 07:00AM

Jul 6, 2021 08:30AM

Jun 3, 2021 07:00AM

May 17, 2021 07:00AM

Apr 26, 2021 08:07AM

Apr 26, 2021 08:00AM

Apr 8, 2021 07:00AM Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial

Mar 31, 2021 08:00AM

Mar 17, 2021 07:00AM

Feb 19, 2021 08:00AM

Feb 1, 2021 07:30AM

Jan 7, 2021 08:00AM

Dec 30, 2020 08:00AM

Dec 17, 2020 08:00AM Algernon Pharmaceuticals Provides Additional Information on Phase 2b/3 Ifenprodil COVID-19 Study Interim Data

Dec 15, 2020 08:15AM

Jun 25, 2020 08:00AM

Jun 4, 2020 12:10PM

May 26, 2020 08:49AM

May 25, 2020 08:00AM

May 15, 2020 08:30AM

Apr 30, 2020 09:15AM Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

Apr 29, 2020 03:09PM

322,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All